Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1997-7-10
|
pubmed:abstractText |
Bcl-2 is an oncogene that confers deregulated growth potential to B lymphocytes through its ability to inhibit apoptotic cell death. A specific molecular activity for the Bcl-2 protein has not been identified, but several lines of evidence have supported a role in protection of cells from oxidative stress. We investigated whether there is a correlation between expression of high levels of Bcl-2 and susceptibility of human Burkitt's lymphoma cell lines to H2O2-induced killing. The amount of H2O2 required to kill 50% of cells in 24 hours varied widely in the seven different lymphoma cell lines that were tested, ranging from 35 to 500 micromol/L H2O2. However, expression of high levels of endogenous Bcl-2 did not protect the cells from H2O2-induced killing, even though it was effective in protecting the cells from apoptosis induced by agents such as A23187. Thus, Bcl-2 was functional in preventing apoptosis but did not act in an antioxidant capacity. The results were confirmed using a Burkitt's lymphoma cell line overexpressing transfected bcl-2. The results may be explained by the observation that H2O2 was inefficient at inducing apoptosis in these mature B-cell lines. Nonapoptotic death induced by H2O2 was not prevented by Bcl-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcimycin,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4480-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9192772-Apoptosis,
pubmed-meshheading:9192772-Burkitt Lymphoma,
pubmed-meshheading:9192772-Calcimycin,
pubmed-meshheading:9192772-Cell Death,
pubmed-meshheading:9192772-Genes, p53,
pubmed-meshheading:9192772-Herpesviridae Infections,
pubmed-meshheading:9192772-Herpesvirus 4, Human,
pubmed-meshheading:9192772-Humans,
pubmed-meshheading:9192772-Hydrogen Peroxide,
pubmed-meshheading:9192772-Neoplasm Proteins,
pubmed-meshheading:9192772-Oxidative Stress,
pubmed-meshheading:9192772-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:9192772-Recombinant Fusion Proteins,
pubmed-meshheading:9192772-Transfection,
pubmed-meshheading:9192772-Tumor Cells, Cultured,
pubmed-meshheading:9192772-Tumor Virus Infections
|
pubmed:year |
1997
|
pubmed:articleTitle |
Bcl-2 does not protect Burkitt's lymphoma cells from oxidant-induced cell death.
|
pubmed:affiliation |
Laboratory of Immunology, Food and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, MD 20892-4555, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|